Breaking News Instant updates and real-time market news.

TRVN

Trevena

$6.03

0.11 (1.86%)

13:03
10/19/16
10/19
13:03
10/19/16
13:03

Meet Trevena: A talk with CEO Maxine Gowen

Trevena (TRVN) is a clinical-stage biopharmaceutical company focused on the development of therapeutics that target G protein coupled receptors, or GPCRs, for the treatment of acute pain. In an exclusive interview with The Fly, the company's CEO Maxine Gowen talked about the company's ongoing clinical trials, upcoming events, market opportunity for its lead drug and much more. Here are some of the highlights: OLICERIDINE TRIALS ON TRACK: Phase 3 trials for the company's primary candidate Oliceridine, or TVR130, for the treatment of moderate to severe acute pain continue to be on track, with top line data still expected in the first quarter of 2017, CEO Gowen said. According to the executive, Trevena believes it will have sufficient data to support a broad label indication for Oliceridine, without the need to do any further trials aside from the ongoing APOLLO studies in bunionectomy and abdominoplasty and the ATHENA multi procedure trial. A bunionectomy is a surgical procedure to remove a bunion, while an abdominoplasty is a cosmetic surgery procedure used to make the abdomen thinner, more commonly known as a "tummy tuck." LESS ADVERSE EFFECTS: Noting that millions of U.S. patients are treated with an intravenous opioid and have to deal with opioid related adverse effects, Gowen explained that Oliceridine was designed specifically to overcome these adverse events. The executive pointed out that Trevena's clinical data, so far, has shown that Oliceridine can deliver a very rapid pain relief at similar levels to morphine, but with fewer opioid related adverse effects, which she believes will improve hospital care for patients. OTHER PRODUCT CANDIDATES: Aside from Oliceridine, Trevena is developing TRV250 for the treatment of episodic migraine and TRV734 for moderate to severe acute and chronic pain. The CEO expects to submit an Investigational New Drug, or IND, application for '250 to the Food and Drug Administration later this year, which should enable the company to start clinical trials next year. Regarding TRV734, Gowen noted that it makes sense to evaluate a potential partnership as the commercialization of the drug for chronic pain is not "an ideal fit" for the company given Trevena's hospital and specialist focus. CAPITAL TO FUND OPERATIONS INTO 2018: The executive told The Fly that the company maintains its prior guidance, estimating to have enough capital to fund operations into 2018, adding that the company does not discuss plans for future financing. "Meet the Company" is The Fly's recurring series of exclusive short interviews with Executive Officers to offer a deeper look inside the company. A more detailed version of this interview to follow.

  • 22

    Oct

  • 13

    Dec

TRVN Trevena
$6.03

0.11 (1.86%)

05/17/16
ROTH
05/17/16
NO CHANGE
Target $14.5
ROTH
Buy
Roth Capital remains a buyer of Trevena
Roth Capital analyst Michael Higgins reiterates a Buy rating and $14.50 price target on Trevena's shares. The analyst says the company announced that its TRV027 failed in Phase 2 and will be discontinuing the program. However, given the relative risk of development between its oliceridine and its TRV027, Higgins is not making any changes to his financial models. Trevena is "well-capitalized," with cash sufficient to fund operations for two years, the analyst tells investors in a research note, adding that he sees the company's shares as being at an "attractive entry point."
03/29/16
FBRC
03/29/16
INITIATION
Target $16
FBRC
Outperform
Trevena initiated with an Outperform at FBR Capital
FBR Capital analyst Christopher James started Trevena with an Outperform rating and $16 price target.
03/02/16
03/02/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Chemical Financial (CHFC) initiated with a Strong Buy at Raymond James by analyst David Long, who believes its pending accretive merger with Talmer Bancorp (TLMR) will provide the base for a more profitable company with strengthened growth prospects. 2. Infinity Pharmaceuticals (INFI) initiated with an Outperform at FBR Capital, with analyst Christopher James saying that duvelisib has the potential to be a first-in-class treatment for specific types of blood cancers. 3. Trevena (TRVN) initiated with a Buy at WallachBeth by analyst Caroline Palomeque, who said Oliceridine may offer patients a treatment option with comparable analgesic efficiency, a faster onset of action and a more favorable safety profile than morphine. 4. Aduro Biotech (ADRO) initiated with an Outperform at FBR Capital. 5. LKQ Corp. (LKQ) initiated with a Buy at Sterne Agee CRT. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/02/16
WBTH
03/02/16
INITIATION
Target $18
WBTH
Buy
Trevena initiated with a Buy at WallachBeth
WallachBeth analyst Caroline Palomeque started Trevena with a Buy rating and $18 price target. The company's lead candidate Oliceridine for post-operative acute pain may offer patients a treatment option with comparable analgesic efficacy, a faster onset of action and a more favorable safety profile than morphine, Palomeque tells investors in a research note.

TODAY'S FREE FLY STORIES

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:16
12/02/16
12/02
17:16
12/02/16
17:16
Periodicals
President Obama blocks China's takeover of Aixtron, CNBC reports »

Says the transaction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$15.74

-0.32 (-1.99%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Periodicals
Deutsche Bank to pay $60M settlement over gold price-fixing case, Reuters says »

Deutsche Bank will pay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

ALB

Albemarle

$84.86

-0.79 (-0.92%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Hot Stocks
Albemarle to increase prices for select brominated products »

Albemarle announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

FOR

Forestar Group

$13.40

0.2 (1.52%)

17:06
12/02/16
12/02
17:06
12/02/16
17:06
Hot Stocks
Breaking Hot Stocks news story on Forestar Group »

Carlson Capital lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$108.14

-1.86 (-1.69%)

17:04
12/02/16
12/02
17:04
12/02/16
17:04
Syndicate
Breaking Syndicate news story on Diamondback Energy »

Diamondback Energy files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSIR

Osiris

$5.68

0.06 (1.07%)

17:02
12/02/16
12/02
17:02
12/02/16
17:02
Hot Stocks
Osiris: Nasdaq grants company's request for additional time »

Osiris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STOR

STORE Capital

$24.45

0.52 (2.17%)

17:00
12/02/16
12/02
17:00
12/02/16
17:00
Hot Stocks
STORE Capital director Donovan acquires 4,350 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARB

Carbonite

$17.95

0.25 (1.41%)

16:48
12/02/16
12/02
16:48
12/02/16
16:48
Hot Stocks
Breaking Hot Stocks news story on Carbonite »

Crosslink lowers stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIB

CGI Group

$47.11

0.16 (0.34%)

16:48
12/02/16
12/02
16:48
12/02/16
16:48
Hot Stocks
CGI Group announces specific share repurchase program »

CGI Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THC

Tenet

$15.05

-0.13 (-0.86%)

, UNH

UnitedHealth

$160.73

-0.21 (-0.13%)

16:45
12/02/16
12/02
16:45
12/02/16
16:45
Hot Stocks
Tenet, UnitedHealthcare renew national relationship for four years »

Tenet Healthcare (THC)…

THC

Tenet

$15.05

-0.13 (-0.86%)

UNH

UnitedHealth

$160.73

-0.21 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$12.24

-0.19 (-1.53%)

16:43
12/02/16
12/02
16:43
12/02/16
16:43
Periodicals
Ford CEO willing to work with Trump to keep jobs in U.S., Bloomberg says »

Ford CEO Mark Fields said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 10

    Jan

BAC

Bank of America

$21.23

-0.27 (-1.26%)

16:40
12/02/16
12/02
16:40
12/02/16
16:40
Options
Long-dated Bank of America calls rolled out to 2019 15 point spread »

Long-dated Bank of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 13

    Jan

DPZ

Domino's Pizza

$168.00

-0.7 (-0.41%)

16:39
12/02/16
12/02
16:39
12/02/16
16:39
Syndicate
Breaking Syndicate news story on Domino's Pizza »

Domino's Pizza files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Jan

ALKS

Alkermes

$56.25

1.36 (2.48%)

16:39
12/02/16
12/02
16:39
12/02/16
16:39
Hot Stocks
Alkermes COO and Chief Risk Officer Gordon Pugh to resign »

On November 29, Mr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.21

-1.3 (-2.22%)

, VRX

Valeant

$15.45

0.14 (0.91%)

16:34
12/02/16
12/02
16:34
12/02/16
16:34
General news
On The Fly: Stocks end week mixed as Trump rally loses steam, oil surges »

The major averages ended…

SBUX

Starbucks

$57.21

-1.3 (-2.22%)

VRX

Valeant

$15.45

0.14 (0.91%)

GM

General Motors

$35.41

-1.02 (-2.80%)

F

Ford

$12.24

-0.19 (-1.53%)

FCAU

Fiat Chrysler

$7.63

-0.11 (-1.42%)

AAPL

Apple

$109.86

0.37 (0.34%)

AMZN

Amazon.com

$740.34

-3.31 (-0.45%)

BX

Blackstone

$25.86

-0.29 (-1.11%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$20.40

0.135 (0.67%)

TIME

Time Inc.

$16.00

-0.2 (-1.23%)

LNEGY

Linde

$16.77

0.09 (0.54%)

PX

Praxair

$119.58

-0.15 (-0.13%)

PH

Parker-Hannifin

$141.90

-1.57 (-1.09%)

CLC

Clarcor

$82.46

-0.12 (-0.15%)

TIF

Tiffany

$81.30

-1.21 (-1.47%)

THO

Thor Industries

$101.48

-1.5 (-1.46%)

SPLK

Splunk

$53.68

0.35 (0.66%)

ASNA

Ascena Retail

$7.01

1.18 (20.24%)

FIVE

Five Below

$43.82

3.94 (9.88%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

AEO

American Eagle

$16.17

-0.57 (-3.41%)

ADSK

Autodesk

$70.57

1.35 (1.95%)

DG

Dollar General

$74.56

1.08 (1.47%)

EXPR

Express

$10.79

0.15 (1.41%)

GES

Guess

$12.91

-0.85 (-6.18%)

WDAY

Workday

$71.40

-10.2 (-12.50%)

ULTA

Ulta Beauty

$253.39

-4.02 (-1.56%)

AMBA

Ambarella

$54.47

-6.92 (-11.27%)

SWHC

Smith & Wesson

$21.10

-2.88 (-12.01%)

UNH

UnitedHealth

$160.73

-0.21 (-0.13%)

CAT

Caterpillar

$95.14

-1.1 (-1.14%)

JPM

JPMorgan

$81.60

-0.19 (-0.23%)

BLK

BlackRock

$371.36

-5.84 (-1.55%)

DIS

Disney

$98.50

-0.44 (-0.44%)

WMT

Wal-Mart

$70.88

0.21 (0.30%)

IBM

IBM

$160.02

0.2 (0.13%)

CTSH

Cognizant

$54.02

-0.06 (-0.11%)

T

AT&T

$38.61

-0.27 (-0.69%)

TWX

Time Warner

$93.80

-0.34 (-0.36%)

GPRO

GoPro

$9.70

-0.12 (-1.22%)

NSANY

Nissan

$18.68

-0.05 (-0.27%)

TM

Toyota

$116.83

-0.94 (-0.80%)

VLKAY

Volkswagen

$27.18

-0.05 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 05

    Dec

  • 05

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

  • 14

    Dec

  • 19

    Dec

  • 20

    Dec

  • 05

    Jan

  • 09

    Jan

  • 09

    Jan

  • 10

    Jan

  • 13

    Jan

  • 16

    Feb

  • 28

    Feb

  • 13

    Mar

  • 14

    Jul

  • 12

    Oct

CASI

CASI Pharmaceuticals

$1.35

0.1009 (8.07%)

16:33
12/02/16
12/02
16:33
12/02/16
16:33
Syndicate
Breaking Syndicate news story on CASI Pharmaceuticals »

CASI Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$18.40

0.6 (3.37%)

16:31
12/02/16
12/02
16:31
12/02/16
16:31
Syndicate
Breaking Syndicate news story on Hi-Crush Partners »

Hi-Crush Partners files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$18.40

0.6 (3.37%)

16:31
12/02/16
12/02
16:31
12/02/16
16:31
Syndicate
Breaking Syndicate news story on Hi-Crush Partners »

Hi-Crush Partners files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
12/02/16
12/02
16:30
12/02/16
16:30
Options
Preliminary option volume of 15.6M today »

Preliminary option volume…

SBUX

Starbucks

$57.21

-1.3 (-2.22%)

, WDAY

Workday

$71.40

-10.2 (-12.50%)

16:28
12/02/16
12/02
16:28
12/02/16
16:28
General news
On The Fly: Top stock stories for Friday »

Stocks began the day with…

SBUX

Starbucks

$57.21

-1.3 (-2.22%)

WDAY

Workday

$71.40

-10.2 (-12.50%)

P

Pandora

$13.33

1.85 (16.12%)

SIRI

Sirius XM

$4.30

-0.255 (-5.60%)

ULTA

Ulta Beauty

$253.39

-4.02 (-1.56%)

BX

Blackstone

$25.86

-0.29 (-1.11%)

GM

General Motors

$35.41

-1.02 (-2.80%)

JPM

JPMorgan

$81.60

-0.19 (-0.23%)

BLK

BlackRock

$371.36

-5.84 (-1.55%)

DIS

Disney

$98.50

-0.44 (-0.44%)

WMT

Wal-Mart

$70.88

0.21 (0.30%)

IBM

IBM

$160.02

0.2 (0.13%)

INFO

IHS Markit

$34.88

-0.23 (-0.66%)

ASNA

Ascena Retail

$7.01

1.18 (20.24%)

FIVE

Five Below

$43.82

3.94 (9.88%)

AMBA

Ambarella

$54.47

-6.92 (-11.27%)

SWHC

Smith & Wesson

$21.10

-2.88 (-12.01%)

ATI

Allegheny Technologies

$16.93

-0.83 (-4.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 08

    Dec

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

  • 09

    Jan

  • 09

    Jan

  • 10

    Jan

  • 13

    Jan

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

FLDM

Fluidigm

$6.68

0.2 (3.09%)

16:25
12/02/16
12/02
16:25
12/02/16
16:25
Hot Stocks
Fluidigm CEO acquires 55,000 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSON

Hudson Global

$1.47

0.01 (0.68%)

16:25
12/02/16
12/02
16:25
12/02/16
16:25
Hot Stocks
Sagard exits stake in Hudson Global »

This was reported in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLA

Delta Apparel

$21.39

0.24 (1.13%)

16:22
12/02/16
12/02
16:22
12/02/16
16:22
Hot Stocks
Delta Apparel chief accounting officer DuVall resigns »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$14.03

-0.04 (-0.28%)

16:20
12/02/16
12/02
16:20
12/02/16
16:20
Options
Closing CBOE SPX and VIX Index summary for December 2nd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EW

Edwards Lifesciences

$83.35

1.88 (2.31%)

16:19
12/02/16
12/02
16:19
12/02/16
16:19
Hot Stocks
Edward Lifesciences' Szyman acquires 12,870 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.